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Current Management of 
Pregnancy in the Diabetic: A Team Approach 
Seth G. Kivnick, M D , * J. David Fachnie, MD, * * and Chang Y. Lee, MD"* 
We reviewed details of 89 pregnancies in diabetic 
women who were delivered from 1980 through 1982. 
Data are presented on the obstetrical outcome and the 
level of diabetic control in patients with White classifica-
tions of B through R. Although the mean blood glucose 
levels of all groups failed to meet the criteria for ideal 
metabolic control (fasting less than 105 mg/dl, post-
prandial less than 120 mg/dl), the perinatal mortality rate 
of 4% compared favorably with reports from other cen-
ters. Fifty-six percent of our patients were delivered at 37 
weeks gestation or later. The primary Caesarean section 
rate was 37%, and the overall section rate was 50%. Rea-
sons for high rates of preterm delivery and Caesarean 
section are analyzed. Management of diabetic pregnan-
cies by a "high risk team" consisUng of an obstetrician, 
diabetologist, dietitian, and neonatologist is described. 
Modern perinatal management, which strives to main-
tain maternal euglycemia and accurately monitor fetal 
well-being and maturity, can virtually eliminate the clas-
sic causes of increased perinatal morbidity and mortality 
in diabetic pregnancies. The challenge for the future is 
to decrease the incidence of congenital anomalies in the 
infants of diabetic mothers. 
Improvements in diagnosis and management of the 
diabetic pregnancy over the last 60 years have markedly 
reduced perinatal mortality rates. In 1922, the Joslin 
Clinic reported no live births to ketosis-prone diabetic 
women (1); but today, perinatal mortality rates in most 
centers are currently less than 10%. Such progress 
reflects an improved understanding of altered carbohy-
drate metabolism in pregnancy, greater insight into the 
effects Of these alterations on the fetuses of diabetic 
mothers, and the development of effective methods for 
assessing fetal wel l-being. 
Diabetes mellitus adversely affects the pregnant woman 
in several ways. Preclampsia-eclampsia is approximately 
four times more common in women with diabetes, with 
or without pre-existing vascular disease. The incidence 
of polyhydramnios and its associated problems is increas-
ed. Urinary tract infections are more common. During 
pregnancy, diabetic ketoacidosis occurs at much lower 
blood sugar levels than it does in nonpregnant diabetic 
patients. Exacerbation of pre-existing vascular disease, 
retinopathy, and nephropathy dur ing pregnancy may 
cause permanent end organ damage (2). Since the fetus 
is frequently larger than average, dystocia and trauma to 
the birth canal may result. Fetal macrosomia and the 
frequent need for preterm delivery require a Caesarean 
section more often than for normal pregnant women. 
Infants of diabetic mothers have an increased risk for a 
number of antenatal and neonatal complications (3). The 
metabolic problems which such infants often encounter 
in the newborn period include hypoglycemia, hypo-
calcemia, hypomagnesemia, hyperbil irubinemia, poly-
cythemia, and the respiratory distress syndrome. These 
problems are frequently compounded by the premature 
delivery necessitated by maternal or fetal compromise. 
The infant may be traumatized during diff icult vaginal 
delivery. Intrauterine fetal death may occur secondary to 
maternal ketoacidosis or near term without apparent 
cause. Finally, diabetes increases the percentage of 
infants born with major congenital anomalies. 
Improvements in the outcome of a diabetic pregnancy, 
both for the mother and the fetus, depend on aggressive 
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perinatal management. Collaboration between obste-
tr ician, diabetologist, dietit ian, and neonatologist is 
essential to achieve excellent metabolic control of the 
pregnant diabetic woman, and close monitor ing of fetal 
maturity and wel l -being, and to ensure atraumatic 
delivery necessary to optimize the management of these 
high-risk pregnancies. 
Materials and Methods 
We have reviewed available records of all women with 
diabetes mellitus who were deivered at Henry Ford 
Hospital f rom January 1, 1980 through December 31, 
1982. Each patient was categorized according to the 
Whi te classification system (Table I). Because complica-
tions related to diabetes are diff icult to demonstrate 
in gestational diabetic patients who do not require insu-
l in, patients in class A (those control led by diet alone) 
were excluded (4). 
During initial evaluation bythe high risk team, particular 
attention was given to the patient's cardiovascular and 
neurologic status. Electrocardiogram and 24-hour urine 
collection to determine total protein and creatinine 
clearance were performed on patients in classes C 
th rough R. Regardless of the duration of their disease, 
these patients were also evaluated by a retinal specialist 
(5), and those with retinopathy underwent regular oph-
thalmologic evaluation. Laser therapy was employed to 
arrest proliferative retinopathy. Glycosylated hemoglobin 
(Hb^ic) concentration was measured for each new patient. 
Except for particularly compliant patients with easily 
control led diabetes, all were admitted to the hospital to 
TABLE I 
Whi te Classification of Diabetes in Pregnant Women 
A Abnormal postprandial glucose; diet contro l led 
B Requires insulin therapy; onset over 20 years o ld ; durat ion 
less than 10 years; no vascular lesions 
C,B Requires insulin therapy; never on insulin before pregnancy 
Cl Age 10-19 years at onset 
C2 Durat ion 10-19 years 
D l Onset at under 10 years 
D2 Over 20 years 'durat ion 
D3 Benign retinopathy 
D4 Calcif ied leg vessels 
D5 Hypertension 
F Nephropathy 
H Cardiopathy 
R Proliferative retinopathy 
T Renal transplant 
complete this evaluation and to achieve optimal gly-
cemic control . Each was counseled by a dietit ian about a 
diabetic diet that would contain 30-35 kcal/kg ideal 
body weight and 100-125 gm protein. A diabetes teach-
ing nurse taught each patient how to inject insulin, to 
monitor her capillary blood glucose by intermittent f in-
ger pricks and chemstrip tests, and to test urine speci-
mens for acetone. 
Insulin therapy initiated dur ing pregnancy consists only 
of puri f ied pork insulin in order to minimize the devel-
opment of insulin antibodies. Almost all patients were 
managed with two or more insulin injections daily. In 
most cases an algorithm was constructed for mult iple 
injections based on preprandial and bedtime home 
blood sugar determinations. Subsequent adjustments 
were made in insulin dosage, as well as in the quantity 
and distr ibut ion of food intake as indicated by acteo-
nuria, adequacy of weight gain, b lood glucose measure-
ments, and symptoms of hypoglycemia or hyperglycemia. 
Patients with sufficient interest and comprehension 
were taught how to adjust their insulin dosages. Metabolic 
goals included fasting blood glucose concentration of 
less than 105 mg/d l , postprandial glucose of less than 120 
mg/d l , no acteonuria, and a weight gain of at least 10-12 
kg over the entire pregnancy. 
The purpose of obstetrical evaluation in the first trimes-
ter is to identify other obstetrical or genetic risk factors. 
Routine prenatal laboratory tests were obtained and 
vitamins prescribed. Estimated date of delivery was 
established as accurately as possible by tradi t ional 
obstetrical landmarks (e.g., auscultation of fetal heart 
tones, fundal height measurement, quickening) as well 
as by an ultrasound examination made between 18 and 
24 weeks of gestation. 
Visits to the high risk clinic and to the diabetologist were 
made biweekly through 28 weeks gestation and weekly 
thereafter. Postprandial venous blood glucose levels 
were determined at each visit, and HbAic concentration 
was measured in each trimester. Some patients required 
interval admissions to the hospital to improve glycemic 
contro l , and most were hospitalized for that purpose at 
least one week before delivery. 
Beginning at 28 weeks, each patient counted and record-
ed the number of fetal movements perceived in a given 
hour each day. This daily recording served as an index of 
fetal well-being. Ultrasound study was repeated in the 
third trimester if fundal height deviated from the stand-
ard growth curve. Nonstress testing (NST) (Fig. 1) was 
done weekly after 32 weeks. In this test, the fetal heart 
rate is continuously monitored for accelerations asso-
35 
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ciated with fetal movements felt by the mother. A "reac-
t i ve" NST (Fig. I A ) , consisting of three or more such 
accelerations within a 10-minute per iod, is a highly spe-
cific indicator of fetal wel l-being. It assures with 99% 
certainty that intrauterine fetal death wil l not occur in 
the week fol lowing a reactive test (6). A "non-react ive" 
NST (Fig. IB) fails to assure fetal well-being and requires 
further evaluation in the form of a contraction stress test 
(CST) (Fig. 2), which involves continuous observation of 
fetal heart rate response to uterine contractions stimu-
lated by intravenous oxytocin. A negative CST (accelera-
tions associated with uterine contractions) indicates the 
safety of prolonging the pregnancy for one week. A 
positive CST (persistent late decelerations with contrac-
tions) indicates uteroplacental insufficiency and the 
need for carefully monitored induction of labor or 
prompt Caesarean section. If CST demonstrated fetal 
distress, stimulation was cont inued, and delivery was 
accomplished promptly. When the fetal condit ion pre-
cluded labor, Caesarean section was performed. 
When the fetal condit ion was good and glycemic control 
satisfactory, delivery was planned for 38 weeks gestation. 
Amniocentesis was performed just before delivery to 
determine chemical indices which correlate with neona-
tal pulmonary maturity. These include the lec i th in / 
sphingomyelin ratio, percentage of desaturated lecithin, 
phosphatidylinosital and phosphatidylglycerol. In these 
53:,:^2 
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Fig.1 
Nonstress Test (NST) 
A. Reactive nonstress test: Fetal heart rate accelerations associated 
w i th fetal movements indicate fetal we l l -be ing. B. Nonreact ive non -
stress test: Further evaluation indicated in fo rm of contract ion stress 
test (CST) or real-t ime ultrasound test. 
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Fig. 2 
Positive contract ion stress test may indicate fetal compromise. 
cases, the route chosen for delivery was based on obstet-
rical factors. When the cervix was favorable, labor was 
induced with administration of oxytocin, and the patient 
was delivered vaginally. Throughout labor, blood glu-
cose concentration was maintained below 120 mg/dl by 
means of continuous intravenous infusions of 5% dex-
trose in normal saline and insulin, along with frequent 
capillary blood glucose determinations by chemstrips. 
Caesarean section, when chosen for other than emer-
gency obstetrical indications, was performed at 8:00 am 
after half the usual dose of intermediate acting insulin 
had been administered. Delivery was attended by a team 
consisting of a neonatologist and special care newborn 
nursery personnel who assigned Apgar scores, per-
formed necessary resuscitative maneuvers, and initiated 
surveillance for hypoglycemia and other metabolic per-
turbations characteristic of infants of diabetic mothers. 
In the immediate postpartum period, maternal blood 
glucose goals were relaxed. Patients usually required 
on l yoneha l f t oone th i r do f t he antepartum insulin dose. 
Results 
Of 89 patients whose charts were reviewed, 46 were 
placed in White classes B through R (Table II). At deliv-
ery, 26 of 46 (56%) were at 37 or more weeks gestation, as 
compared to 90% of all obstetrical patients at our institu-
t ion. Eight were at 36 weeks gestation. Of the remaining 
12, indications for preterm delivery were premature rup-
ture of membranes in two cases, intrauterine fetal death 
in two cases, fetal distress in one case, worsening mater-
nal hypertension in three cases, and elective delivery of 
an infant with laboratory evidence of pulmonary maturity 
in four cases. 
TABLE II 
Obstetrical Data for 46 Diabetic Pregnant Women 
total rate including repeat Caesarean sections was 50%. 
Overall rate of performance of this operation at Henry 
Ford Hospital during the study period was 9.13% primary 
87 
Number of White Mean age Mean weeks % C-section 
patients (46) class (years) gestation Primary/Total 
at delivery 
27 8 31 36.3 41/48 
8 C 26 36.1 22/33 
9 D 28 36.2 38/67 
2 R 29 35 50/50 
The primary Caesarean section rate was 37%, while the 
Kivnick, Fachnie, and Lee 
and 14.2% total. The indications for primary section were 
failure of induction in four cases (at 32.5,36.5, 37, and 38 
weeks gestation), fetal distress in three cases, cephalo-
pelvic disproport ion in three cases, breech presentation 
in two cases, and one case each of hypertension, trans-
verse lie, chorioamnionit is, and fetal prematurity. 
Data on the relationship between maternal metabolic 
control and fetal outcome (Table III) indicate that con-
sistent, ideal glycemic control (fasting glucose less than 
105 mg/d l and postprandial levels less than 120 mg/dl) 
was not achieved in any White class, although mean 
glucose levels in the two Class R patients were within 
stated metabolic goals. 
TABLE III 
Comparison of Maternal Metabol ic Cont ro l and Fetal 
Outcome in 46 Diabetic Pregnant Women 
Whi te Mean Mean Mean % over % 5 min lUFD* 
class FBS RBS birth 4000 Apgar < 8 
mg/dl mg/d l weight gms 
(gms) 
B 115 157 3336 11 7 1 
C 97 146 3335 25 13 1 
D 118 160 3150 11 0 0 
R 80 110 3180 0 0 0 
' In t rauter ine fetal death 
Twelve percent of the infants weighed more than 4000 
gm at bir th. Apgar scores of lower than eight at five 
minutes of life occurred in 5% of Class B, none of Class C, 
and 22% of Class D offspring. 
Two perinatal deaths occurred in the 46 cases reviewed 
(4%). One child was born with congenital anomalies 
incompatible with life. Another was already dead in 
utero when its mother presented in ketoacidosis for 
initial evaluation at 30 weeks gestation. 
Discussion 
The relationship between maternal glucose control and 
perinatal mortality in diabetic pregnancies was first 
demonstrated by Karlsson and Kjellmar (7). In 1972 they 
observed a perinatal mortality rate of 38 per 1000 if mean 
maternal glucose levels dur ing the third trimester were 
kept below 100 mg/d l . If mean glucose levels exceeded 
150 mg /d l , perinatal mortality was 236 per 1000. Since 
glucose diffuses freely across the placental interface, 
maternal hyperglycemia rapidly causes fetal hypergly-
cemia. Long-term hyperglycemia induces fetal islet cell 
hyperplasia and subsequent hyperinsulinemia. As a 
result, the deposition of proteins, glycogen, and fat 
increases, as can be seen in the macrosomic infant of a 
poorly control led diabetic mother. Such infants are 
likely to be traumatized at birth because of their large 
size. The abrupt withdrawal of maternal glucose at birth 
may result in l ife-threatening fetal hypoglycemia, since 
reduced insulin secretion by the neonatal pancreas 
occurs only gradually. Less marked hypoglycemia occurs 
in neonates whose mothers were well control led. 
Another major cause of perinatal mortality is intrauter-
ine fetal death wi thout ketoacidosis, which may also be 
related to poorly control led maternal blood sugar. Shel-
ley, et al, in a sheep model , demonstrated that fetal 
hyperglycemia, when accompanied by minimal hypoxia, 
produced fatal lactic acidosis (8). Beard and Oakley hy-
pothesized that maternal hypoglycemia combined with 
fetal hyperinsulinemia caused intrauterine fetal death 
(9). Al though much remains to be learned about the 
mechanisms of the diabetic environment, its deleterious 
effects on the fetus and newborn, as well as the correla-
t ion between good maternal glucose control and im-
proved fetal outcome, are now well established. 
The present study was l imited in several ways. Our 
review of charts yielded insufficient data on maternal 
glycemic control to allow us to apply statistical tests of 
significance. Nor were we able to draw conclusions 
about the relationship between level of control and 
birth weight. This cohort of patients was heterogeneous 
with respect to the point in gestation at which each was 
referred to the high risk obstetrical clinic for manage-
ment. The intrauterine fetal death which had occurred 
in the woman who presented herself initially at 30 weeks 
wi th ketoacidosis might have been prevented if t ight 
metabolic control had been instituted earlier. The inci-
dence of fetal death in ketoacidosis is 50% or more (10). 
Home blood glucose monitor ing provides great advan-
tages over home urine glucose testing and also over 
periodic measurement of blood glucose at clinic visits. 
Patients use home blood glucose readings and algo-
rithms constructed by the diabetologist to adjust insulin 
doses promptly. However, the cost of these techniques 
may limit their application; self-monitoring of blood 
glucose may cost up to $1,000 annually. In addit ion to 
initial hospitalization or intensive outpatient education, 
these patients also require weekly phone contact, as the 
physician must be readily accessible to advise about 
insulin dose adjustments. 
Modern techniques to evaluate fetal maturity and wel l -
being account for much of the decrease in perinatal 
mortality rates seen in diabetic pregnancies over the past 
decade. As recently as the 1960s (11), fetal deaths not 
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associated with ketoacidosis were encountered in 10-
30% of diabetic pregnancies. Sincethe incidence of such 
deaths increases after 36 weeks, it became common 
practice to deliver diabetic gravidas several weeks before 
term. This practice, however, often resulted in iatro-
genic prematurity and subsequent neonatal deaths. 
More than 50% of such neonatal deaths were due to 
hyaline membrane disease (10), which is five to six times 
more common in infants of diabetic mothers in White 
classes A, B, and C than in the newborns of nondiabetic 
mothers (12). On theotber hand, in classes D through R, 
maternal microangiopathy exposes the fetus to chronic 
stress, which seems to accelerate pulmonary maturity. 
Delayed lung maturity also appears to be caused by fetal 
hyperinsulinism, which inhibits the stimulation of pul-
monary surfactant product ion by fetal Cortisol (13). We 
perform biochemical analysis of the components of 
pulmonary surfactant in amniotic f luid to ascertain fetal 
lung maturity before elective delivery. Such f luid is 
obtained by amniocentesis as soon as preterm delivery 
seems indicated by either maternal or fetal compromise, 
other than in emergency situations. The ratio of lecithin 
to sphingomyelin, which is an extremely accurate index 
of pulmonary maturity in normal fetuses, has been reported 
to be less accurate in diabetic patients (14). Testing for 
the presence of phosphatidylglycerol (another compo-
nent of surfactant) along with the lecithin/sphingomye-
lin ratio improves the accuracy of our predict ion of 
pulmonary maturity to 99% (15). 
Biophysical methods to assess fetal wel l-being allow 
infants to be delivered closer to term wi thout increased 
risk of antepartum fetal death. Recognition that the 
heart rate of a healthy fetus accelerates in association 
with vigorous (i.e., perceivable by the mother) activity 
led to the acceptance of nonstress testing as a primary 
means of antepartum fetal moni tor ing (16,17). As a bio-
physical screening method for fetal compromise, we 
have our patients at 28 weeks gestation begin to count 
and record the number of perceived movements in the 
same hour each day. The basis for this "k ick sheet" is the 
observation that a decrease in fetal activity is an early 
indicator of fetal compromise (18). A kick count of fewer 
than five in two hours or a significant drop in kicks per 
hour requires immediate NST evaluation. 
Many indirect biochemical methods to assess fetal well-
being have been tested. The most successful are mater-
nal urinary and plasma estriol determinations. Since the 
fetus plays an essential role in the biosynthesis of estriol 
(involving both fetal adrenal and liver functions), fetal 
compromise may decrease the concentration of estriol 
in maternal b lood or urine (6). To be of use in making 
decisions about obstetrical management, such meas-
urements must be made daily on 24-hour urine collec-
tions. Normal daily variation in estriol production requires 
that each day's measurement be compared with the 
mean of the previous three. However, because the spe-
cificity and sensitivity of estriol as a predictor of fetal 
outcome have been questioned (19), and because of 
logistical problems with their use, estriol studies have 
been discarded in favor of direct, biophysical methods 
of assessing fetal well-being. 
We are concerned about the overall Caesarean section 
rate of 50% in this group of patients. The rate for all 
patients delivered at Henry Ford Hospital during the 
study period was 14.2% (9.2% primary). Caesarean sec-
t ion wi thout attempt at induct ion of labor was used 
liberally in the past for preterm delivery of diabetic 
women. Fetal kick counts or nonstress testing should 
increase the number of diabetic pregnancies which can 
be allowed to develop to 38 weeks gestation or longer. 
At that point, induction of labor is more likely to suc-
ceed. In this report, failure of induct ion was the most 
prevalent indication for abdominal delivery, and 75% of 
such failures occurred before 38 weeks. In addit ion, 
continuous fetal heart rate moni tor ing in labor now 
enables us to diagnose incipient but correctable fetal 
distress. Reducing the risks of unexpected intrauterine 
death and intrapartum fetal compromise by improved 
antepartum and intrapartum surveillance should dimin-
ish the incidence of elective sections before term and 
at term. 
Nonetheless, this report reflects a cont inuing tendency 
toward preterm delivery as soon as amniocentesis dem-
onstrates pulmonary maturity. The pressure to deliver 
soon after fetal lung maturity has been confirmed is 
especially great when managing patients with previous 
fetal losses at or near term. Such practice is likely to 
perpetuate relatively high section rates. 
Our perinatal mortality rate of 4% (2/46) is similar to rates 
recently reported by other centers (7,20,21). Fetal and 
neonatal deaths due to prematurity, birth trauma, intra-
uterine death unassociated with ketoacidosis, and neo-
natal metabolic complications can now be prevented by 
careful metabolic control and accurate assessment of 
fetal maturity and well-being. 
One o f the major challenges facing perinatologists in the 
1980s is to prevent congenital anomalies in the offspring 
of diabetic patients. In many series, birth defects are the 
leading cause of perinatal mortality (6). Such birth 
defects, which caused one of our two losses, occur in up 
to 20-36% of infants born to diabetic mothers. The most 
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common anomalies involve the heart and skeletal sys-
tem. Recent data demonstrate an association between 
glycosylated hemoglobin levels at seven to eight weeks 
gestation and the incidence of congenital anomalies 
seen at delivery (22). These data indicate that the level of 
glycemiccontrol at ferti l ization and during the period of 
organogenesis is a critical determinant of teratogenesis 
in these infants. Ideal care of pregnancies complicated 
by diabetes must begin with t ightening of glycemic con-
trol when a diabetic woman begins to contemplate con-
ception. To realize this goal, all physicians who treat 
diabetic women in the reproductive age group must 
help. Only when aggressive management is practiced 
f rom before conception though the postpartum period 
are the diabetic woman's chances for successful preg-
nancy maximized. 
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S o m e M u s c u l o s k e l e t a l P r o U e m s 
A s s o c l a f e t l w i f t D i a l k e t e s 
Peri-capsulitis of the shoulders and hips • Diabetic cheiroarthropathy 
Flexor tenosynovitis • Diffuse idiopathic skeletal hyperostosis 
Carpal tunnel compression • Dupuytren's contraaure 
• Neuropathic arthropathy (Charcot joint) 
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